You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Advanced Malignancies

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Advanced Malignancies Trial in Guangzhou (BRY812 for injection)

Not yet recruiting
  • Advanced Malignancies
  • BRY812 for injection
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital，Sun Yat-sen University
Sep 7, 2023

Advanced Cancer Trial (AB801, Zimberelimab, Docetaxel)

Not yet recruiting
  • Advanced Cancer
  • (no location specified)
Nov 1, 2023

Advanced Malignant Cancer Trial (HRS-7053 Injection)

Not yet recruiting
  • Advanced Malignant Cancer
  • HRS-7053 Injection
  • (no location specified)
Aug 7, 2023

Non Small Cell Lung Cancer, Triple Negative Breast Cancer, Hodgkin Lymphoma Trial (CTX-8371)

Not yet recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • (no location specified)
Dec 4, 2023

Advanced Solid Tumor Trial in Xiamen, Jinan, Linyi (FP002 Injection)

Recruiting
  • Advanced Solid Tumor
  • FP002 Injection
  • Xiamen, Fujian, China
  • +2 more
Aug 9, 2023

Colorectal Cancer, GIST Trial (DCC-3116, Ripretinib, Cetuximab)

Not yet recruiting
  • Colorectal Cancer
  • GIST
  • (no location specified)
Jul 14, 2023

Advanced Malignancies, Solid Tumor, Hematological Malignancy Trial in Canton, Gettysburg, West Valley City (Pelabresib)

Recruiting
  • Advanced Malignancies
  • +2 more
  • Canton, Ohio
  • +6 more
Jan 30, 2023

Advanced Cancer, Advanced Malignancies, Bladder Cancer Trial (AB598, Zimberelimab, Carboplatin)

Not yet recruiting
  • Advanced Cancer
  • +11 more
  • (no location specified)
May 26, 2023

Efficacy and Safety of ICIs as First-line Therapy for Advanced

Not yet recruiting
  • Malignant Tumor
  • +2 more
    • Chongqing, Chongqing, China
      the second affiliated hospital of Army medical university
    May 16, 2023

    Advanced Cancer, Advanced Solid Tumor, Cancer Trial in Scottsdale, San Antonio (STC-15)

    Recruiting
    • Advanced Cancer
    • +2 more
    • Scottsdale, Arizona
    • +1 more
    Dec 18, 2022

    Advanced Cancer Trial in Houston (Dasatinib, Bevacizumab, Paclitaxel)

    Completed
    • Advanced Cancer
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Nov 21, 2022

    Triple Negative Breast Cancer, Clear Cell Renal Cell Carcinoma, Ovarian Cancer Trial in Austin, San Antonio, Fairfax (BDC-3042,

    Recruiting
    • Triple Negative Breast Cancer
    • +5 more
    • Austin, Texas
    • +2 more
    Sep 19, 2023

    NSCLC, Gastric Cancer, Head Neck Cancer Trial (CDX-585)

    Not yet recruiting
    • Non-small Cell Lung Cancer
    • +13 more
    • (no location specified)
    Mar 29, 2023

    Cancer, Solid Tumor, Hematologic Malignancy Trial in Hangzhou (engineered red blood cell WTX212)

    Recruiting
    • Cancer
    • +2 more
    • engineered red blood cell WTX212
    • Hangzhou, Zhejiang, China
      Zhejiang Provincial People'S Hospital
    Jan 21, 2023

    Relapse, Advanced Malignant Tumor, Non Small Cell Lung Cancer Trial in India (AUR106)

    Not yet recruiting
    • Relapse
    • +7 more
    • Visakhapatnam, Andhra Pradesh, India
    • +5 more
    May 7, 2023

    Advanced Solid Tumor, Lymphoma Trial in United States (ALPN-202, Pembrolizumab)

    Active, not recruiting
    • Advanced Solid Tumor
    • Lymphoma
    • Atlanta, Georgia
    • +4 more
    Nov 8, 2022

    Relapsed Malignant Solid Tumor Trial in India (AUR107)

    Not yet recruiting
    • Relapsed Malignant Solid Neoplasm
    • Vijayawada, Andhra Pradesh, India
    • +6 more
    May 9, 2023

    Platinum-resistant Ovarian Cancer, Endometrial Cancer, Cervical Cancer Trial in New Brunswick, Buffalo, Pittsburgh (Drug Product

    Active, not recruiting
    • Platinum-resistant Ovarian Cancer
    • +2 more
    • Drug Product De-TIL-0255
    • New Brunswick, New Jersey
    • +3 more
    Nov 15, 2022

    Primary Condition: Advanced Tumors Trial in Guangzhou (JS009 as a monotherapy and JS009 as a Triple Combination Therapy in

    Not yet recruiting
    • Primary Condition: Advanced Tumors
    • JS009 as a monotherapy and JS009 as a Triple Combination Therapy in Combination with Toripalimab and JS006
    • Blacktown, New South Wales, Australia
    • +3 more
    Feb 1, 2023

    Advanced Malignant Tumor Trial (SHR-5495 for injection)

    Not yet recruiting
    • Advanced Malignant Tumor
    • SHR-5495 for injection
    • (no location specified)
    Sep 26, 2023

    Cancer, Advanced Malignancies Trial in Greenville, Ottawa, Montreal (BBI608)

    Completed
    • Cancer, Advanced Malignancies
    • Greenville, South Carolina
    • +2 more
    Apr 4, 2022

    Tumors, Colorectal Cancer Trial in Grand Rapids, Nashville, Kirkland (MK-8353, Pembrolizumab)

    Completed
    • Neoplasms
    • Colorectal Cancer
    • Grand Rapids, Michigan
    • +2 more
    Dec 21, 2022

    Advanced Malignancies Trial in Harbin (TWP-102 injection)

    Recruiting
    • Advanced Malignancies
    • TWP-102 injection
    • Harbin, Heilongjiang, China
      Harbin Medical University Cancer Hospital
    Mar 7, 2022

    Previously Treated, Advanced, Malignancies Trial (TAB006, Toripalimab)

    Withdrawn
    • Previously Treated, Advanced
    • Malignancies
    • (no location specified)
    May 24, 2022

    Advanced Malignancies Trial in Tianjin (IBI397, IBI397+Sintilimab, IBI397+Rituximab)

    Not yet recruiting
    • Advanced Malignancies
    • Tianjin, Tianjin, China
      Tianjin Medical University Cancer Institute and Hospital
    Feb 8, 2022